Symbol
| KAL2
|
Location
| 8p11.22
|
Name
|
Kallmann syndrome 2 |
Other name(s)
|
anosmic isolated hypogonadotrophic hypogonadism
hypogonadotropic hypogonadism 2 with or without anosmia |
Corresponding gene
|
FGFR1
|
Other symbol(s)
| IHH, aIHH, HH2
|
Main clinical features
|
isolated hypogonadotrophic hypogonadism in association with olfactory abnormalities
complete or partial absence of endogeneous gonadotropin-releasing hormone (GnRH) - induced gonadotropin secretion or action |
Genetic determination
| autosomal dominant |
Function/system disorder
| endocrinology |
| multisystem/generalized |
Type
| disease
|
Name
| fibroblast growth factor-8 receptor 1
|
Gene mutation | Chromosome rearrangement | Effect | Comments |
|
---|
missense
|  
| abnormal protein/loss of function
| multiple mutations
| frameshift
|  
| abnormal protein/loss of function
|  
| insertion
|  
| abnormal protein/loss of function
|  
| |
Remark(s)
|
loss-of-function mutations in KAL1 and FGFR1 account for approximately 20% of all cases of Kallmann syndrome and mutations in the PROKR2 and PROK2 genes account for an additional 10% (Dode,06) |